Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $139M | $165M | $185M | $197M | $192M |
| Revenue growth | — | — | 18.3% | 12.4% | 6.4% | -2.5% |
| Operating income | — | $34.6M | -$60.7M | $28.7M | $31.6M | $35.6M |
| Operating margin | — | 24.8% | -36.8% | 15.5% | 16.0% | 18.5% |
| Net income | — | $11.1M | -$969K | $3.32M | $3.16M | $27.0M |
| Net margin | — | 8.0% | -0.6% | 1.8% | 1.6% | 14.1% |
| EPS (diluted) | — | — | -$0.12 | $0.13 | $0.09 | $0.74 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | $33.7M | -$9.16M | $26.9M | $45.2M | $35.2M |
| Capital expenditures | — | $1.45M | $333K | $359K | $6.43M | $5.01M |
| Free cash flow | — | $32.3M | -$9.49M | $26.5M | $38.8M | $30.2M |
| Share buybacks | — | — | — | — | $5.60M | $3.37M |
| Dividends paid | — | $11.4M | $12.9M | $8.69M | $4.74M | $1.73M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.59K | $130K | $79.2M | $89.0M | $39.3M | $24.1M |
| Total assets | $148K | $54.3M | $112M | $155M | $122M | $108M |
| Total liabilities | $123K | $50.2M | $170M | $192M | $225M | $158M |
| Long-term debt | — | $32.0M | $112M | $107M | $101M | $95.8M |
| Shareholders' equity | $0.00 | $4.13M | -$44.5M | -$29.4M | -$106M | -$58.5M |
| Retained earnings | $0.00 | $4.17M | -$44.5M | -$29.4M | -$100M | -$49.5M |
| Shares (wtd avg diluted) | — | — | 8.06M | 25.7M | 34.3M | 36.7M |
Every figure is extracted from biote Corp.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.